ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872,000 | +23.0% | 160,000 | +39.1% | 0.01% | -35.3% |
| Q2 2023 | $2,335,650 | -44.2% | 115,000 | -49.9% | 0.02% | -5.6% |
| Q1 2023 | $4,187,904 | +305.0% | 229,600 | +359.2% | 0.02% | +63.6% |
| Q4 2022 | $1,034,000 | +58.1% | 50,000 | +100.0% | 0.01% | +83.3% |
| Q3 2022 | $654,000 | -16.8% | 25,000 | -19.4% | 0.01% | 0.0% |
| Q2 2022 | $786,000 | +148.7% | 31,000 | +210.0% | 0.01% | +50.0% |
| Q1 2022 | $316,000 | -78.3% | 10,000 | -88.2% | 0.00% | -81.8% |
| Q3 2020 | $1,457,000 | -46.5% | 85,000 | -22.7% | 0.02% | -54.2% |
| Q2 2020 | $2,721,000 | – | 110,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |